跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 58 条关于
“Vogenx”
全部
58
临床试验
9
药物
12
机构
9
资讯
28
2个月前
Vogenx raises $81.3M in Nasdaq IPO to advance SGLT1 inhibitor mizagliflozin in metabolic disorders
去年
Cogent Biosciences' Bezuclastinib Shows Promise in Systemic Mastocytosis Trials
去年
Cogent Bio Presents Bezuclastinib Data Highlighting Long-Term Benefits in Non-Advanced Systemic Mastocytosis
2年前
argenx Outlines 'Vision 2030' with Focus on Autoimmune Disease Therapies
去年
VIGex and ctDNA Analysis Improves Immunotherapy Response Prediction in Solid Tumors
10个月前
Cogent Biosciences Raises $475.3 Million to Advance Bezuclastinib for Systemic Mastocytosis
10个月前
Cogent Biosciences Unveils Promising KRAS Inhibitor Data with Superior Efficacy Profile
去年
Argenx Partners with Unnatural Products in $1.5 Billion Macrocyclic Peptide Deal
去年
VYVDURA Approved in Japan for Chronic Inflammatory Demyelinating Polyneuropathy
去年
Cogent Biosciences Secures $400M Debt Financing to Advance Bezuclastinib Through Pivotal Trials
第 1 页,共 3 页
上一页
下一页